Jaguar Health Inc. (JAGX)
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
POET Technologies Provides Purchase Order Update
Telos Corporation to Announce First Quarter 2026 Financial Results on May 11, 2026
Getty Images Selected as Official Photographer of 2026 Met Gala
Immediate Report on the Status of Holdings of Interested Parties and Senior Officers
M-tron Industries, Inc. Announces Completion of Rights Offering
Adial Pharmaceuticals Submits Application to FDA Commissioners National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
TeaPot® Declares Second Saturday in May “Take Your Mom to the Dispensary Day”
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program